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Abstract 
The aggregation of α-synuclein is a critical event in the pathogenesis of neurological diseases, such 
as Parkinson or Alzheimer. Here, we present a label-free sensor based on an Electrolyte-Gated 
Organic Field-Effect Transistor (EGOFET) integrated with microfluidics that allows us to detect 
amounts of α-synuclein in the range from 0.25 pM to 25 nM. The lower limit of detection (LOD) 
measures the potential of our integrated device as a tool for prognostics and diagnostics. In our 
device, the gate electrode is the effective sensing element as it is functionalized with anti-(α-
synuclein) antibodies using a dual strategy: i) an amino-terminated self-assembled monolayer 
activated by glutaraldehyde, and ii) the His-tagged recombinant protein G. In both approaches, 
comparable sensitivity values were achieved, featuring very low LOD values at the sub-pM level. 
The microfluidics engineering is central to achieve a controlled functionalization of the gate 
electrode and avoid contamination or physisorption on the organic semiconductor. The 
demonstrated sensing architecture, being a disposable stand-alone chip, can be operated as a point-
of-care test, but also it might represent a promising label-free tool to explore in-vitro protein 
aggregation that takes place during the progression of neurodegenerative illnesses.  
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α-synuclein is a small protein formed by 140 amino acids (19-20 kDa), which, in its pathological 
condition, is a component of the so-called Lewy Body inclusions. This protein has been considered 
as a possible hallmark of a group of neurodegenerative diseases, known as synucleinopathies, 
which include Parkinson’s disease (PD), the second most common neurodegenerative disease 
(Chang et al., 2020; Goedert et al., 2017; Gould et al., 2014; Spillantini and Goedert, 2000). 
Furthermore, α-synuclein has also been shown to play a role in the pathophysiology of Alzheimer's 
disease (AD) (Twohig and Nielsen, 2019; Wennström et al., 2013). Specifically for PD, there are 
still no conclusive results about the correlation between the specific levels of circulating α-
synuclein in plasma and cerebrospinal fluid (CSF) with the clinical diagnosis and progression of 
this illness, which has been mainly accounted by variations in the assays detection and 
sensitivity/accuracy (Bougea et al., 2019; Shi et al., 2010). Thus, the development of highly 
sensitive devices able to detect this protein in the range from nM down to pM is required for the 
diagnosis and prognostics of PD and the understanding of the correlation of the α-synuclein levels 
on its evolution.  
Label-free immunosensors that exploit an organic semiconductor channel as the transducer of the 
biorecognition events are emerging as ultrasensitive and highly specific devices for bioanalytical 
assays, with figures of merit often comparable, sometimes even superior (with levels of detection 
down to a few target molecules), to those characterizing the workhorse of bioanalytical techniques 
viz. the enzyme-linked immunosorbent assays (ELISA) (Engvall and Perlmann, 1971). In 
comparison to label-free electronic sensors based on inorganic semiconductors, as CHEM-FETs 
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(i.e., chemical field-effect transistors (Kaisti, 2017)) or MOSFETs (i.e., metal-oxide field-effect 
transistors (Guo et al., 2015)), organic biosensors offer other important advantages, such as the 
closer proximity with the aqueous environment (the organic semiconductor channel is immersed 
in the biologically relevant fluid), the stability of operations in aqueous electrolytes (the typical 
hysteresis and bias stress observed in ambient operations of organic electronics devices disappear 
in the liquid environment), the possibility to be interfaced or integrated as arrays with living 
systems, thanks to the large-area manufacturing on flexible substrates and a suitable bio/functional 
interface. 
Two main device architectures are used for organic transistors as biosensors in aqueous liquids: i) 
electrolyte-gated organic field-effect transistors (EGOFETs) (Kergoat et al., 2010) and ii) organic 
electrochemical transistors (OECTs) (Loïg Kergoat et al., 2012). EGOFETs rely on the capacitive 
coupling between the gate electrode and the active material, whereas OECTs exploit the ion 
diffusion along with the electrochemical doping of the active material (Rivnay et al., 2018). 
Relevant bio-applications include electroceuticals (Jonsson et al., 2016), bioelectric signal 
recording (Campana et al., 2014; Cramer et al., 2013), neuromorphic devices (Desbief et al., 2016; 
Van De Burgt et al., 2017), and biosensors (Casalini et al., 2015, 2013; Parkula et al., 2020; Wang 
et al., 2019). 
In the case of EGOFET biosensors, the functionalization with a biorecognition group can be done 
either at the gate electrode (Casalini et al., 2013), or at the organic semiconductor channel (Torsi 
et al., 2013, 2008). Magliulo et al. (Magliulo et al., 2016) successfully demonstrated both 
physisorption and chemical grafting of sensing receptors onto the semiconducting channel 
achieving excellent results towards the quantification of streptavidin and C-reactive protein in a 
wide range of concentrations, namely from 1 µM to 10 nM and from 2 µM to 2 pM, respectively. 
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However, the approach exerted by using a functionalized gate is generally more convenient, 
because it avoids the surface engineering of the organic semiconductor, which can affect its 
electrical properties and stability during the aqueous operation.  As a result, a  number of metal 
functionalization strategies have been successfully demonstrated such as the grafting of 
antibodies/aptamers mediated either by the Protein G or by self-assembled monolayers (SAMs) 
(Berto et al., 2019, 2016; Casalini et al., 2015; Magliulo et al., 2016, 2013; Torsi et al., 2013; Wang 
et al., 2019). The ultimate achievement was the effective detection down to single-molecule of 
immunoglobulins G/M by co-functionalizing the gate electrode with a SAM endowed with 
hydrogen-bonding interactions that amplify the individual biorecognition event by a cooperative 
reorientation of the SAM (Macchia et al., 2018). As the limits of detections are pushed down to 
such low concentrations, and since many relevant biomarkers, even when overexpressed, are 
present at extremely low concentration during their patho-physiological condition (e.g. 
inflammatory cytokines), it is crucial to guarantee the electrical stability in these label-free devices. 
This is particularly important aiming at a new generation of biosensing point-of-care (POC) 
systems or early diagnostic tools for the detection of relevant biomarkers. Thus, the effort on 
engineering the optimal interface immunochemistry must be paralleled by the effort in endowing 
the sensor with compact microfluidics able to guarantee the required stability of parameters during 
the measurement. The success of such microfluidics has been extensively explored in other types 
of label-free devices such as the electrochemical (Guo, 2016; Huang et al., 2019) as well as optical 
ones, (Xu et al., 2019; Zeng et al., 2019). These excellent examples share the same goal, namely a 
compact chip to be used as a  POC test (Xu et al., 2018). 
Here, we report on an α-synuclein label-free sensor based on an EGOFET as electronic 
transduction, whose gate electrode is functionalized by a monoclonal anti-(α-synuclein) antibody. 
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Two different surface functionalization strategies to graft the anti-(α-synuclein) antibody (i.e. 
SAM and Protein G) are explored. The EGOFET sensor is integrated into a novel microfluidics 
layout designed ad-hoc to standardize the measurements. This microfluidics consists of separately 
accommodating the gate and the organic semiconductor, thereby avoiding cross-contamination 
during the sample dispensing, even though their electrical connection is always preserved for its 
proper operation. Additionally, the microfluidic is crucial to avoid the fast evaporation of 
solvent/water, which would produce a temporal drift of the target concentration and hence of the 
relevant electrochemical potentials in the device. The microfluidic embedded EGOFET featuring 
a coplanar gate reaches a sensitivity up to 37(±5) mV/dec and a limit-of-detection (LOD) as low 
as 0.25 pM in phosphate buffered saline (PBS) solution at pH= 7.2 performing analytical tests that 
take only a few minutes.  
2. Materials and methods 
2.1. Materials 
Human α-synuclein, glutaraldehyde (25% wt), potassium chloride, sodium phosphate dibasic, 
iron(III) ferrocyanide, polystyrene (MW 10000 g/mol), chlorobenzene, 2,3,4,5,6-
pentafluorothiophenol, dextran (from Leuconostoc Mesenteroides, MW= 64.000-76.000 g/mol), 
and gold wire (Ø 0.5 mm) were purchased from Sigma Aldrich. Sodium chloride and glycerol 
were purchased from Panreac Quimica. Recombinant His-tagged Protein G was obtained from 
BioVision, Inc. HS–(CH2)11–(OCH2CH2)6–NH2∙HCl (abbreviated as HSC11EG6NH2) was 
purchased from ProChimia Surfaces. The anti-(α-synuclein) antibody α-synuclein(211) was 
purchased from Santa Cruz Biotechnology, Inc. The organic semiconductor, 2,8-Difluoro-5,11-
bis(triethylsilylethynyl)anthradithiophene (diF-TES-ADT), was obtained from Lumtec. Acetone 
and isopropanol were purchased from Chem-Lab and used without further purification. Kapton® 
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foils were bought from DuPont (Kapton®HN, 75 μm thick). Qsil216 A/B (polydimethylsiloxane, 
PDMS) was purchased from Farnell Componentes. 
2.2. Electrochemistry setup 
Electrochemical characterization of the sensing platform was realized with a 
potentiostat/galvanostat Autolab (PGSTAT128N). The measurements were carried out in a 
standard three-electrode configuration cell by using Pt, Ag/AgCl, and Au as the counter, reference, 
and working electrode, respectively. 
Electrochemical Impedance Spectroscopy (EIS) was recorded between 0.1 MHz to 0.1 Hz with an 
AC amplitude equal to 10 mV. The setpoint voltage was the redox potential of the ferricyanide 
probe. The impedance response was fitted by means of Randles circuit, whose components are the 
solution resistance (Rs) in series with the charge transfer resistance (RCT) and the Warburg element 
(W), whereas in parallel the double-layer capacitance (Cdl) (Bard and Faulkner., 2002). 
Cyclic voltammetry (CV) was measured at different scan rates (10 mV/s, 30 mV/s, 60 mV/s, 90 
mV/s, 100 mV/s, 200 mV/s, 300 mV/s, 400 mV/s, 500 mV/s), sweeping the potential from -0.1 V 
to 0.45 V. Differential Pulse Voltammetry (DPV) was recorded sweeping the potential from -0.1 
V to 0.5 V, at a sweep rate equal to 10 mV/s and its modulation amplitude equal to 25 mV. For the 
reductive desorption of thiols from Au surface, DPV was recorded sweeping the potential from -
0.1 V to -1.4 V in NaOH 1 M. 
The whole batch of electrochemical measurements was performed in an aqueous solution 
containing K3[Fe(CN)6] 5 mM, KCl 100 mM, and 50 mM of sodium phosphate buffer. The 
different pHs were adjusted by using small aliquots of NaOH or HCl 1 M. The non-faradaic 
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measurements were carried out in a solution of KCl (100 mM) and sodium phosphate (50 mM) at 
pH 7.2. 
2.3. X-Ray Photoelectron Spectroscopy 
XPS measurements were performed at room temperature with a SPECS PHOIBOS 150 
hemispherical analyzer (SPECS GmbH, Berlin, Germany) in a base pressure of 5x10-10 mbar using 
monochromatic Al K-alpha radiation (1486.74 eV) as the excitation source. 
2.4. Surface Plasmon Resonance 
For the characterization of the bio-functionalized Au surface by means of Surface Plasmon 
Resonance (SPR) technique, it was used a SPR platform (Sensia ß-SPR), that employs the 
Kretschmann configuration and incorporates two flow cells (300 nL each) for an independent 
analysis. The sample is a 1 cm2 gold chips (2 nm Cr, 50 nm Au), whereas the whole setup works 
in a semi-automated way. The flow rate was set at 25 μL/min. The sensor surface was excited with 
a 670 nm light source. Gold chips were cleaned according to the following protocol: sonication in 
Acetone, EtOH, and bidistilled water for 1 min respectively. The final step consisted of exposing 
the surface to the UV Ozone cleaner for 30 minutes. All the functionalization steps were carried 
out in-situ and measured in real-time except for the amino-terminated thiols adsorption, which was 
carried out ex-situ because of the incompatibility of the microfluidics tubes with EtOH. 
2.5. Device fabrication and measurement 
The substrate used for EGOFETs fabrication was Kapton®. Source, Drain, and Gate electrodes 
when required, were patterned by positive photolithography. A thin layer of Au was evaporated, 
namely 5 nm of Cr (as an adhesive layer) and 40 nm of Au. The channel length (L) and width (W) 
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were fixed to 30 μm and 18400 μm (i.e. W/L ratio equal to 613) respectively. After the metal 
deposition, the substrates were cleaned by sonication in acetone and isopropanol. The devices were 
then exposed to UV Ozone cleaner for 25 minutes. Subsequently, the chip was immersed in a 
solution of 2,3,4,5,6-pentafluorothiophenol (PFBT, 2 μL/mL in isopropanol) for 15 minutes to 
functionalize the gold source-drain contacts, rinsed with isopropanol and dried over N2. In the 
devices with the coplanar gate electrode, before the source-drain PFBT functionalization, the 
planar gate electrode was passivated by a thick coating of dextran (i.e. drop-casting of a dextran 
solution 10 mg/mL) (Leonardi et al., 2018). Such a sacrificial layer was removed by immersing 
the device in water after the deposition of the organic semiconductor in order to leave the gate 
electrode uncovered. 
The organic semiconductor deposition method selected was the so-termed Bar-Assisted Meniscus 
Shearing (BAMS) (Temiño et al., 2016). A blend of 2,8-Difluoro-5,11-
bis(triethylsilylethynyl)anthradithiophene (diF-TES-ADT) and polystyrene Mw= 10000 g/mol 
(viz. PS10k) was dissolved in chlorobenzene 2% wt with a ratio of 4:1. The solution was deposited 
at 10 mm/s and 105 ºC as previously reported. (Zhang et al., 2016) 
The electrical characterization was performed by using a two-channel Keithley Source Meters 
2400 and 2601 controlled with a homemade Matlab script, under ambient temperature and dark 
condition. The device was conditioned by applying VGS = -0.1 V and VDS = -0.1 V until the IDS 
reached a steady state. Afterwards, transfer characteristics were recorded in the linear regime. For 




2.6. Ex-situ bio-functionalization of the Au wires surfaces and sensing measurements for the 
top-gated EGOFETs 
The polycrystalline Au wire was cleaned according to the following protocol: (i) immersion in 
NaOH 1 M, heating at above 100 ˚C for 15 minutes, (ii) immersion in concentrated H2SO4 heating 
at above 100 ˚C for 15 minutes, (iii) Au electropolish by sweeping the potential from -0.1 V to 1.6 
V (15 cycles in H2SO4 1 M, as solvent). The functionalization protocols for approach I consisted 
of the following steps: 
(i) incubation in the solution of HSC11EG6NH2 (1 mM EtOH) at 4 °C overnight. The Au wire 
was successively rinsed with EtOH and bidistilled water and dried by N2 flow. 
(ii) Activation of the amino-group by dipping the HSC11EG6NH2-coated wire in a solution of 
glutaraldehyde (2.5% wt in water) at 4°C for 1 h, and successively rinsed with bidistilled water. 
(iii) Incubation into the antibody solution (40 µg/mL in PBS 1x pH 7.2) at RT for 15 minutes. 
Approach II relies on the following steps: 
(i) Incubation in Recombinant His-tag protein G solution (140 µg/mL in PBS 1x pH 5.5) at 
RT for 15 minutes. 
(ii) Incubation into the anti-(α-synuclein) antibody solution (40 µg/mL in PBS 1x pH 5.5) at 
RT for 15 minutes. 
The α-synuclein solutions were prepared by subsequent dilution starting from 1 mg/mL 
concentration in PBS 1x pH 7.2. The Ab-coated Au surfaces were incubated for 15 minutes at R.T. 
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with α-synuclein solutions of increasing concentrations in the range from 0.25 pM to 250 nM, and 
finally abundantly rinsed with PBS 1x pH 7.2 before measurements. 
2.7. Microfluidics fabrication for coplanar gate electrode devices 
The microfluidic device was constituted by two main parts: i) the inner chamber in 
Polydimethylsiloxane (PDMS) which contains the PBS solution and ii) the outer holder that serves 
as a support for the Kapton® substrate and properly fixes the PDMS chamber on it. In order to 
fabricate the chamber and the holder, 3D drawings were made using SketchUp 2017 software (see 
Supporting Information, Fig.S1). A master for the PDMS chamber and the holder were printed by 
means of Digital Light Processing (DLP) 3D printer model “B9Creator V1.2HD”. The resin of 
choice was “B9R-2-Black”. A Sylgard® 184 silicone elastomer was used to create a liquid solution 
of PDMS and was deposited over the 3D printed mould and cured in oven at 70 °C for 12 h. When 
the curing process was finished, PDMS microfluidic chamber was removed from the mould and 
fixed over the planar electrodes on the Kapton® substrate. It features a microfluidic channel of 500 
μm height and a flexible channel connecting both chambers. 
2.8. Functionalisation of the coplanar Au-gate by using the microfluidics and subsequent 
sensing experiments with the coplanar gate EGOFETs  
The self-assembled monolayer formation on the coplanar gate electrode was carried out ex-situ by 
PDMS-assisted printing technique (Leonardi et al., 2018). Afterwards, the microfluidics setup was 
assembled and the chambers were filled with the electrolyte solution from Inlet, employing a 
peristaltic pump from Watson-Marlow (400 series pump). At this point, activation of the SAM 
amino-groups by glutaraldehyde (100 µL, 2.5% v/v) and subsequent Ab (50 µL, 40 µg/ml) 
immobilization was performed in-situ, by injecting the corresponding solutions from Inlet2 at a 
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flow rate equal to 10 µl/min, connecting simultaneously a peristaltic pump at the Outlet to pump 
out the same fluid. Then, buffer solution (PBS 1mM) was injected at 10 µl/min through Inlet2 in 
order to wash away physisorbed biomolecules, approximatively for 5 minutes. 
The subsequent α-synuclein sensing was performed in-situ, by injecting the solution containing 
the receptors (50 µl) at a flow rate of 10 µl/min from Inlet2, for about five minutes. After each 
functionalization step, a fresh PBS 1x solution was streamed through Inlet2 for at least 3 minutes 
in order to remove the physisorbed molecules. Finally, the flow was stopped and three transfers 
were recorded in the linear regime, measuring the device with the sensing gate. The concentrations 
of α-synuclein solution sensed were the following: 0.25 pM, 2.5 pM, 25 pM, 250 pM, 2.5 nM, 25 
nM, 250 nM. Each sensing experiment started and finished with an electrical characterization by 
exploiting the reference gate electrode in order to cross-check the overall operation status of the 
organic semiconductor.  
3. Results and discussion 
3.1. Characterization of the sensing platforms 
Anti-(α-synuclein) antibodies (Abs) have been tethered onto the polycrystalline Au by means of 
two different approaches, the so-termed “approach I” and “approach II” (Figure 1). The former 
relies on an amino-terminated pegylated thiol (HSC11EG6NH2), whose amino groups have been 
successively activated with glutaraldehyde (Gl) (Betancor et al., 2006; Walt and Agayn, 1994). 
This leads to a functionalized Au extremely reactive towards primary amines, which are usually 
abundant in the Abs backbone (see Fig.1(top)). The second approach does not covalently graft the 
antibody to the surface but instead tethers it to the His-tagged recombinant Protein G (PG), which 
is anchored to the Au electrode. PG can target efficiently the crystallizable Ab region (Choe et al., 
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2016; Song et al., 2012; Young et al., 2005). Furthermore, PG is robustly anchored to the 
polycrystalline Au thanks to its His tag that exhibits an affinity towards different metals such as 
Ni and Au (Fig. 1(bottom)) (Iori et al., 2008; Yang and Zhao, 2007). Since there is not an 
established protocol for tethering a bio-molecule onto a metal surface without affecting partially 
its bio-functionality, we pursued both approaches that have pros and cons and compared the 
outcomes of the sensing devices in order to establish the most suitable approach. For instance, 
approach I yields covalent albeit random Ab grafting, whereas approach II guarantees more 




Figure 1. a) Scheme of the Au surface functionalization protocol with Approach (top) I and 
(bottom) II. b) Scheme of the EGOFET fabrication, including the gate functionalisation, organic 
semiconductor deposition and EGOFET implementation. 
 
Our first goal was to verify the presence of the surface binders (viz. HSC11EG6NH2-based SAM 
and PG), their reactivity towards Abs and, consequently, their sensitivity towards -synuclein. 
Electrochemical means (i.e., electrochemical impedance spectroscopy, differential pulse 
voltammetry and cyclic voltammetry) were used for this purpose. The PG grafting yielded a 
pronounced area normalised RCT increase (RCT) up to 20 k/cm2 and a consequent decrease of 
the current density (J) down to 440 A/cm2 (Fig.2a,b and Fig. S2 for the CV characterisation). 
As expected, the HSC11EG6NH2-based SAM features higher RCT (120 k/cm2) than PG due to 
its more ordered and compact packing onto the Au surface (see Fig.2c). Measurements by XPS 
and further electrochemical measurements support this evidence (see Fig.S3, S4, and S5, 
Supporting Information). Both functionalization approaches were successfully tested towards a 
0.25 µM solution of α-synuclein proving their sensing ability towards this analyte. In particular, 
the two approaches exhibit opposite trends of the response with respect to Abs adsorption and 
detection of α-synuclein. The HSC11EG6NH2-based SAM (i.e. higher coverage and molecular 
packing) showed an increase of RCT and a consequent J decrease (Fig.2d and Fig.S2) after being 
incubated with α-synuclein. Conversely, PG showed a decrease of RCT and a consequent J 
increase (i.e. lower coverage and molecular packing). Albeit it is beyond the scope of this paper, 
these experimental proofs hint at a relevant redistribution of the surface charge on the metal due 
to the pairs Ab-PG as well as Ab-PG-synuclein. Besides, the different responses could also be 




Figure 2. EIS and DPV characterization of the Ab functionalized surface. Approach I. (a) EIS: 
SAM-coated Au (red curve), Ab-SAM-coated Au (blue curve), after incubation in a solution of α-
synuclein 0.25 μM (green curve). In the inset, the curve relative to pristine Au is represented, (b) 
DPV: SAM-coated Au (red line), Ab-SAM-coated Au (blue line), after incubation in a solution of 
α-synuclein 0.25 μM (green line). In the inset, the DPV of pristine Au is reported. Approach II. (c) 
EIS: bare Au (black curve), PG-coated Au (red curve), Ab-PG-coated Au (blue curve), after 
incubation in a solution of α-synuclein 0.25 μM (green curve). (d) DPV: PG-coated Au (red line), 
Ab-PG-coated Au (blue line), after incubation in a solution of α-synuclein 0.25 μM (green line). 
 
In order to further characterize the functionalized substrates, we used surface plasmon resonance 
(SPR) to assess the two approaches on a planar Au film (Fig.3). As explained in the experimental 
section, the SPR is equipped with microfluidic channels that allow real-time monitoring of the 
absorption process. The excellent sensitivity of this technique allowed us to track the reflected 
light variation (%ΔR), which is directly related to the Au surface grafting. In particular, ΔR as a 
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function of time allows one to monitor the kinetics of this phenomenon. Apart from demonstrating 
the successful glutaraldehyde activation of HSC11EG6NH2-based SAM in approach I, as well as 
the PG adsorption on gold in approach II, the transient ΔR change related to the surface 
functionalization with anti-(α-synuclein) Ab was monitored and exponentially fitted for both 
approaches (Ab concentration was fixed at 40µg/ml). Hence, the growth factors (f) were calculated 
(see Fig.S6, Supporting Information). It turned out that approach I was faster than approach II 
yielding f = 112 (1) s and f = 212 (1) s, respectively. Although a calibration curve and more 
advanced measurements would be required for achieving a quantitative analysis, it can be stated 
that approach II leads to the adsorption of more anti-(α-synuclein) Ab (ΔR = 12) with respect to 
approach I (ΔR = 6). Concerning the α-synuclein recognition (concentration selected equal to 250 
nM), a larger ΔR is recorded for approach II with respect to approach I. Thus, these data do not 
only hint a larger amount of anti(α-synuclein) Ab in approach II, but also an improved control of 
Ab orientation onto the Au surface. In agreement with the electrochemistry results, SPR 
measurements confirm the successful Ab functionalization of the surfaces employing both 
approaches, as well as their capability to sense α-synuclein.
 




3.2. Top-gated EGOFETs: α-synuclein detection 
Since both approaches turned out to be extremely responsive towards α-synuclein, we employed 
them as gate terminals into a standard EGOFET architecture (see Fig.1b). This allows one to 
monitor the detection of α-synuclein by using a transistor. Concerning the general architecture of 
the device, we choose Kapton® as a flexible supporting substrate for the interdigitated electrodes. 
The channel area was coated by a thin-film blend composed of the organic semiconductor 2,8-
Difluoro-5,11-bis(triethylsilylethynyl)anthradithiophene (diF-TES-ADT, Fig.4a) and polystyrene 
(PS) deposited by bar-assisted meniscus shearing (BAMS), as reported earlier (Fig.1b) (Del Pozo 
et al., 2016; Leonardi et al., 2018; Temiño et al., 2016; (Zhang et al., 2016). As previously 
published, the role of PS improves the general stability of the electrical performances, especially 
when operated in liquid (Campos et al., 2018; Leonardi et al., 2016; Paterson et al., 2016; Pérez-
Rodríguez et al., 2018; Temiño et al., 2016b; Zhang et al., 2016a; Zhao et al., 2016). This is 
achieved due to the vertical phase separation of the two components that takes place during the 
deposition; in other terms, the organic semiconductor crystallizes sandwiched between a bottom 
PS layer and a top thin skin PS layer. Finally, the device was exposed to phosphate-buffered saline 
(PBS) solution at pH 7.2, where a top gate electrode was immersed, namely an Au wire (Fig. 1b).  
The I-V transfer characteristics were acquired after the ex-situ functionalization of the gate with 
anti-(α-synuclein) Ab. Subsequently, the electrode was immersed in benchmark solutions of α-
synuclein and, afterwards, implemented as a top gate electrode in the standard EGOFET layout 
(Fig.4a). This guaranteed no chemical and/or biological contamination onto the organic 
semiconductor surface. Prior to any sensing experiment, electrical conditioning was always 
performed (i.e., VDS and VGS equal to -0.1 V for 20 minutes) and the ex-situ functionalization was 
verified step by step by recording at least three transfers for each step (Fig.4b,c). Aiming at 
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avoiding misleading interpretation, additional I-V transfer characteristics were acquired at the end 
of each sensing experiments by using a freshly cleaned Au wire (viz. gate electrode). This allowed 
us to verify if any extrinsic phenomena (such as bias stress or damaging of the semiconducting 
film) related to the device were contributing to the recorded trends (see Fig.S7, Supporting 
Information). These final cross-checks elucidated the direct interplay between the 
functionalization steps and the electrical changes occurring at the transistor. Two well-defined 
trends were observed corresponding to the two approaches. In particular, approach I shows a 
positive shift of the I-V transfer after exposure of the gate to an increasing concentration of α-





Figure 4. (a) Molecular structure of diF-TES-ADT and PS. I-V transfer characteristics of the 
EGOFET (VDS = -0.1 V) with (b) Ab-SAM-coated Au gate (approach I) and (c) Ab-PG-coated Au 
gate (approach II), upon interaction with α-synuclein. The sensing response for both approaches 













As widely reported in the literature, an organic or biological coating assembled onto the gate 
surface or the semiconducting material can drastically affect the electrical performance of the 
transistor operated in aqueous media (Berto et al., 2017, 2016; Casalini et al., 2013; Loig Kergoat 
et al., 2012; Roberts et al., 2008; Torsi et al., 2013). The introduction of surface dipoles can either 
build-up an additional potential into the device or lead to a relevant change of the electrical double-
layer capacitance. Aiming at a more quantitative description, we extracted the ΔV solely related to 
the bio-molecular recognition event regardless of the device-to-device variability, which affects 
usually the threshold voltage. For this reason, our data have been extracted by adopting the 
mathematical elaboration suggested by Ishikawa et al.(Duan et al., 2012; Ishikawa et al., 2009; 
Lee et al., 2011), as follows: 
 
where ΔI=(IDS,ini-IDS,fin ) is the difference between the IDS,ini related to the device functionalized by 
the anti-(α-synuclein) Ab and the IDS,fin corresponding to a specific concentration of antigen, and 
gm is the maximum transconductance (namely the first derivative of IDS versus VGS). In particular, 
it has been decided to verify our device sensitivity at the gate bias, where the gm is the highest, 
namely -0.07 V (see Fig. S9, Supporting Information). At the end of the sensing experiments, 
approach I yields a shift of +111(±20) mV, while an opposite shift of -111(±29) mV is found in 
approach II. In accordance with the electrochemical data, our EGOFETs sensed two opposite 
trends corresponding to the two functionalization approaches (Fig.4d,e).  
Concerning approach I, the sensing trend can be explained by considering the outer charges arising 
from the α-synuclein (Hammock et al., 2013). As reported in the literature, α-synuclein has an 
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isoelectric point (pI) equal to 4.67, thus it is negatively charged at physiological pH (viz. pH > pI) 
(Gould et al., 2014). As a result, a p-doping effect takes place due to an increase of negative charges 
onto the gate electrode. This leads to an extra accumulation of positive charge carriers into the 
conductive channel of diF-TES-ADT. Furthermore, the response ranges from 0.25 pM to 1 nM 
featuring a sensitivity equal to 21(±2) mV/dec. On the contrary, a rationalization based on simply 
the PI of α-synuclein does not hold for approach II due to the presence of different biomolecules 
on the surface. In this case, the sensing range appears wider than in approach I, namely from 0.25 
pM to 250 nM, with a sensitivity of -16(±2) mV/dec. In other terms, both approaches reveal similar 
sensitivities, but approach II reached two orders of magnitude higher the upper limit of the 
sensitivity range. This outcome is consistent with the SPR assays, which qualitatively pointed to a 
more efficient Au electrode for the detection of α-synuclein in approach II. Furthermore, both 
approaches show comparable LOD values, namely at sub-pM concentration. This high sensitivity 
makes these devices well-suited to study pathological versus physiological levels of this biomarker 
(Lee et al., 2006). 
3.3. Coplanar gating: in-situ (bio)-functionalization 
Although top-gated architecture allowed us to verify the sensibility of our functionalized 
EGOFET, this technology can be solely used at the laboratory scale for proof-of-concept. Aiming 
at more sound technology, a coplanar gate architecture is demanded along with a well-suited 
microfluidic cell for the sample handling. The coplanar architecture improves intrinsically the 
electrical characterization of such a device, because it exerts an ideal control of the gate area 
immersed in the aqueous solution. Furthermore, it allows a straightforward implementation to 
more sophisticated circuitry, because no mobile electrodes are used like the Au wire in the top gate 
architecture.  In our case, we designed two planar gates termed “reference” and “sensing” (Fig.5a). 
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According to this layout, we manufactured a microfluidic cell composed of two well-defined 
chambers, so-termed “chamber 1” and “chamber 2”. The former contains the reference gate along 
with the source/drain electrodes covered by the organic semiconductor, whereas the latter hosts 
the sensing gate. These chambers are joined together by a “connecting channel”, whose role is 
fundamental for the overall functioning of this self-standing chip (Fig.5a). This connecting channel 
guarantees the electrical connection between the sensing gate and the organic semiconductor 
through the electrolyte media. Furthermore, it enables to inject the sample containing α-synuclein 
or antibodies in “chamber 1” avoiding the cross-contamination of the organic semiconductor. In 
other terms, chamber 1 together with the connecting channel are always filled by phosphate buffer, 
and chamber 2 is filled with different solutions (as mentioned in the experimental part, section 
2.8). The use of peristaltic pumps together with the narrow section of the connecting channel 
guarantees the proper functioning of the chip. This has been experimentally verified by using the 
reference electrode to characterize the electrical performance of the organic semiconductor at the 
beginning as well as at the end of the sensing experiments (Fig.S10, Supporting Information). In 
the Supporting Information, it is included a video showing that no cross-contamination occurs 
between the two chambers when “chamber 1” is filled up with a dye solution ( Video 1, Supporting 
Information). 
The scheme of the microfluidic device has been validated with finite element analysis to calculate 
the velocity field and the concentration of α-synuclein within the geometric spaces occupied by 
the solution during infilling of either buffer solution or biological sample (see Supporting 
Information for further details). Navier Stokes equation for momentum balance and convection-
diffusion equation for the transport of dilute species have been solved in combined iterations with 
Comsol Multiphysics ®, in order to account for the dependence of viscosity on concentration and 
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evaluate the time-dependent evolution of the analyte concentration.  The velocity field of the 
solution inside the chamber with the functionalized gate is plotted in Fig.5c, where it is possible 
to appreciate the unperturbed state of the chamber above the interdigitated electrodes. The 
boundary condition for the flow rate, set by the peristaltic pumps (10 μl/min), is inducing a velocity 
field showing the maximum intensity near the widening section of the inlet, with a parabolic like 
profile decaying towards the sides of the microfluidic chamber. Due to laminarity, the streamlines 
extracted by simulation show that the fluid in the connecting channel between the two chambers 
is not displaced by the injection of the sample. The evolution in time of the α-synuclein 
concentration within the simulated geometry is plotted in Fig.5d. The resulting concentration of 
the α-synuclein is affected by convection and diffusion within the sensing chamber, whereas the 
only diffusion is controlling the front advancing towards the chamber of the interdigitated 
electrodes. After 10 minutes from the injection, the value of α-synuclein concentration resulting 
from the simulation is negligible in the volume of the solution above the interdigitated electrodes, 
while it is equal to sample concentration above the functionalized gate. The geometry occupied by 
the electrolyte has been simulated also for evaluating electrostatic potential distribution between 
the functionalized gate and interdigitated electrodes (Poisson equation) with electrical permittivity 
reported for PBS buffer solution (i.e., VGS= -0.6 V). The calculated contour of potential across the 




Figure 5. (a) 3D scheme of the microfluidic setup. (b) Real image of the microfluidic setup filled 
with red and blue dyes, the sensing chamber and the device chamber, respectively (see video and 
more details in SI). (c) Velocity field inside the microfluidics during sample injection resulting 
from finite element simulation. (d) Concentration of α-synuclein within Chamber 2 after 10 
minutes from the injection. (e) Potential contour plot in electrolyte between sensing gate and 
interdigitated electrodes. 
 
Coplanar architecture in microfluidics was tested using approach I. The sensing gate was in-situ 
functionalized (see experimental part for more details, section 2.8). Subsequently, the sensing 
experiments were also performed in-situ by injecting the α-synuclein solutions for 5 minutes and 
then rinsing 3 minutes with the electrolyte media (see Experimental section). The I-V transfer 
characteristics were acquired by spanning the gate-source voltage from 100 mV to -400 mV and 
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with a VDS = -0.1 V. (Fig.6a). The data turned out to be coherent with the previous experiments 
related to the top gated EGOFETs. As a result, positive doping was observed by increasing the α-
synuclein concentrations in the range 0.25 pM-25 nM, reaching a LOD of 0.25 pM, ΔV value as 
high as +166(±52) mV and a slight increase in sensitivity (37(±5) mV/dec) with respect to the top 
gated devices (Fig.6b and Fig.S11, Supporting Information). Although future work should be 
devoted to test biological fluid samples, a high selectivity can be envisaged due to the high binding 
affinity between the Ab used with α-synuclein (Kumar et al., 2020). 
 
 
Figure 6. (a) Transfer characteristics (VDS = -0.1 V) of the sensing experiment employing the 
EGOFET with Ab-SAM-coated coplanar-gate Au gate and (b) relative calibration curve. 
 
4. Conclusions 
A sensing platform based on a dual gate coplanar electrolyte-gated organic field-effect transistor 
in a microfluidic chamber has been demonstrated to detect α-synuclein, a hallmark of 
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neurodegeneration in important pathologies like Parkinson’s and Alzheimer’s down to LOD equal 
to 0.25 pM. The optimum immuno-detection strategy based on anti-(α-synuclein) monoclonal 
antibody was inferred by a comparative study of two surface functionalization routes of the gate 
electrode. Both showed similar sensitivities and LOD values, but they showed different response 
range, namely approach II had a wider range than approach I (viz. 0.25 pM - 250 nM versus 0.25 
pM - 1 nM, respectively). The microfluidics layout has been designed to avoid cross-contamination 
between the sensing gate and the organic semiconductor. Such an approach allowed us the in-situ 
functionalization of the sensing gate and the electrical tests with reference solutions of α-synuclein. 
The herein reported devices combine the high sensitivity and short measurement tests, with the 
electrical readout and the simplicity and upscaling compatibility of the fabrication methods 
employed (see Table S1 for a collection of the figures of merit of state-of-the-art α-synuclein 
sensors which have been described). Thus, these devices showed excellent potential for the 
prognostics and diagnosis of synucleinopathies such as PD, and also can provide a promising label-
free tool for gaining insights into the role of α-synuclein and its aggregation mechanism, which is 
pivotal for a comprehensive understanding of such neurodegenerative diseases. Future work will 
be devoted to fabricate technologically more advanced devices to validate them in a larger set of 
samples and test our label-free sensors using real samples from patient’s fluids. 
 
Acknowledgments 
This work was funded by the EXPLORA project MAT2015-72760-EXP and ERC StG 2012-
306826 e-GAMES. The authors also thank the DGI (Spain) project FANCY CTQ2016-80030-R 
and GENESIS PID2019-111682RB-I00, the Generalitat de Catalunya (2017-SGR-918), the 
27 
 
Networking Research Center on Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN) 
and the Spanish Ministry of Economy and Competitiveness, through the “Severo Ochoa” 
Programme for Centers of Excellence in R&D (SEV-2015-0496). S. R. acknowledges FPU 
Fellowship from the Ministry and is enrolled in the PhD program of the Universitat Autònoma of 
Barcelona (UAB). The research leading to these results has also received funding from the People 
Programme (Marie Curie Actions) of the Seventh Framework Programme of the European Union 
(FP7/2007-2013) under Research Executive Agency Grant Agreement No. 600388 
(TECNIOSpring programme), and from the Agency for Business Competitiveness of the 
Government of Catalonia, ACCIÓ.  The Surface Plasmon Resonance (SPR) measurements were 
performed through the ICTS NANBIOSIS platform, more specifically in the Biodeposition and 
Biodetection Unit of the CIBER in Bioengineering, Biomaterials & Nanomedicine (CIBER-BBN) 
at the Catalan Institute of Nanoscience and Nanotechnology (ICN2). The microfluidic device 
design and fabrication were performed with funding from the European Union’s Horizon 2020 
research and innovation programme under the Marie Skłodowska-Curie grant agreement 764281 
(AiPBAND), and Marie Skłodowska-Curie grant agreement 813863 (BORGES). 
References 
Bard, A.J., Faulkner., L.R., 2002. Electrochemical Methods: Fundamentals and Applications, 
America. 
Berto, M., Casalini, S., Di Lauro, M., Marasso, S.L., Cocuzza, M., Perrone, D., Pinti, M., 
Cossarizza, A., Pirri, C.F., Simon, D.T., Berggren, M., Zerbetto, F., Bortolotti, C.A., 
Biscarini, F., 2016. Biorecognition in organic field effect transistors biosensors: The role of 
the density of states of the organic semiconductor. Analytical Chemistry 88, 12330–12338. 
28 
 
Berto, M., Diacci, C., D’Agata, R., Pinti, M., Bianchini, E., Lauro, M. Di, Casalini, S., Cossarizza, 
A., Berggren, M., Simon, D., Spoto, G., Biscarini, F., Bortolotti, C.A., 2017. EGOFET 
Peptide Aptasensor for Label-Free Detection of Inflammatory Cytokines in Complex Fluids. 
Advanced Biosystems 2, 1700072. 
Berto, M., Vecchi, E., Baiamonte, L., Condò, C., Sensi, M., Di Lauro, M., Sola, M., De Stradis, 
A., Biscarini, F., Minafra, A., Bortolotti, C.A., 2019. Label free detection of plant viruses 
with organic transistor biosensors. Sensors and Actuators, B: Chemical 281, 150–156. 
Betancor, L., López-Gallego, F., Hidalgo, A., Alonso-Morales, N., Dellamora-Ortiz, G., Mateo, 
C., Fernández-Lafuente, R., Guisán, J.M., 2006. Different mechanisms of protein 
immobilization on glutaraldehyde activated supports: Effect of support activation and 
immobilization conditions. Enzyme and Microbial Technology 39, 877–882. 
Bougea, A., Stefanis, L., Paraskevas, G.P., Emmanouilidou, E., Vekrelis, K., Kapaki, E., 2019. 
Plasma alpha-synuclein levels in patients with Parkinson’s disease: a systematic review and 
meta-analysis. Neurological Sciences 40, 929–938. 
Campana, A., Cramer, T., Simon, D.T., Berggren, M., Biscarini, F., 2014. Electrocardiographic 
recording with conformable organic electrochemical transistor fabricated on resorbable 
bioscaffold. Advanced Materials 26, 3874–3878. 
Campos, A., Riera-Galindo, S., Puigdollers, J., Mas-Torrent, M., 2018. Reduction of Charge Traps 
and Stability Enhancement in Solution-Processed Organic Field-Effect Transistors Based on 
a Blended n-Type Semiconductor. ACS Applied Materials and Interfaces 10, 15952–15961. 
Casalini, S., Dumitru, A.C., Leonardi, F., Bortolotti, C.A., Herruzo, E.T., Campana, A., Oliveira, 
29 
 
R.F. De, Cramer, T., Garcia, R., Biscarini, F., 2015. Multiscale Sensing of Antibody À 
Antigen Interactions by Organic Transistors and Single-Molecule Force Spectroscopy. ACS 
Nano 9, 5051–5062. 
Casalini, S., Leonardi, F., Cramer, T., Biscarini, F., 2013. Organic field-effect transistor for label-
free dopamine sensing. Organic Electronics 14, 156–163. 
Chang, Chun Wei, Yang, S.Y., Yang, C.C., Chang, Chia Wen, Wu, Y.R., 2020. Plasma and Serum 
Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson’s Disease. Frontiers 
in Neurology 10, 1–7. 
Choe, W., Durgannavar, T.A., Chung, S.J., 2016. Fc-binding ligands of immunoglobulin G: An 
overview of high affinity proteins and peptides. Materials 9, 994. 
Cramer, T., Chelli, B., Murgia, M., Barbalinardo, M., Bystrenova, E., De Leeuw, D.M., Biscarini, 
F., 2013. Organic ultra-thin film transistors with a liquid gate for extracellular stimulation 
and recording of electric activity of stem cell-derived neuronal networks. Physical Chemistry 
Chemical Physics 15, 3897–3905. 
Del Pozo, F.G., Fabiano, S., Pfattner, R., Georgakopoulos, S., Galindo, S., Liu, X., Braun, S., 
Fahlman, M., Veciana, J., Rovira, C., Crispin, X., Berggren, M., Mas-Torrent, M., 2016. 
Single crystal-like performance in solution-coated thin-film organic field-effect transistors. 
Advanced Functional Materials 26, 2379–2386. 
Desbief, S., Casalini, S., Guerin, D., Tortorella, S., Barbalinardo, M., Kyndiah, A., Murgia, M., 
Cramer, T., Biscarini, F., Vuillaume, D., 2016. Electrolyte-gated organic synapse transistor 
interfaced with neurons. Organic Electronics 38, 21–28. 
30 
 
Duan, X., Li, Y., Rajan, N.K., Routenberg, D.A., Modis, Y., Reed, M.A., 2012. Quantification of 
the affinities and kinetics of protein interactions using silicon nanowire biosensors. Nature 
Nanotechnology 7, 401–407. 
Engvall, E., Perlmann, P., 1971. Enzyme-linked immunosorbent assay (ELISA) quantitative assay 
of immunoglobulin G. Immunochemistry 8, 871–874. 
Goedert, M., Jakes, R., Spillantini, M.G., 2017. The Synucleinopathies: Twenty Years on. Journal 
of Parkinson’s Disease 7, S51–S69. 
Gould, N., Mor, D.E., Lightfoot, R., Malkus, K., Giasson, B., Ischiropoulos, H., 2014. Evidence 
of native α-synuclein conformers in the human brain. Journal of Biological Chemistry 289, 
7929–7934. 
Guo, J., 2016. Uric Acid Monitoring with a Smartphone as the Electrochemical Analyzer. 
Analytical Chemistry 88, 11986–11989. 
Guo, J., Ai, Y., Cheng, Y., Li, C.M., Kang, Y., Wang, Z., 2015. Volumetric measurement of human 
red blood cells by MOSFET-based microfluidic gate. Electrophoresis 36, 1862–1865. 
Hammock, M.L., Knopfmacher, O., Naab, B.D., Tok, J.B.H., Bao, Z., 2013. Investigation of 
protein detection parameters using nanofunctionalized organic field-effect transistors. ACS 
Nano 7, 3970–3980. 
Huang, X., Xu, D., Chen, J., Liu, J., Li, Y., Song, J., Ma, X., Guo, J., 2019. Smartphone-based 
analytical biosensors. Anales de la Quimica 143, 5339–5351. 
Iori, F., Corni, S., Felice, R.D., 2008. Unraveling the interaction between histidine side chain and 
31 
 
the Au(111) surface: A DFT study. Journal of Physical Chemistry C 112, 13540–13545. 
Ishikawa, F.N., Curreli, M., Chang, H., Chen, P., Zhang, R., Cote, R.J., Thompson, M.E., Zhou, 
C., 2009. A Calibration Method for Nanowire Biosensors to Suppress Device-to-Device 
Variation. ACS Nano 3, 3969–3976. 
Jonsson, A., Inal, S., Uguz, L., Williamson, A.J., Kergoat, L., Rivnay, J., Khodagholy, D., 
Berggren, M., Bernard, C., Malliaras, G.G., Simon, D.T., 2016. Bioelectronic neural pixel: 
Chemical stimulation and electrical sensing at the same site. Proceedings of the National 
Academy of Sciences 113, 9440–9445. 
Kaisti, M., 2017. Detection principles of biological and chemical FET sensors. Biosensors and 
Bioelectronics 98, 437–448. 
Kergoat, L., Herlogsson, L., Braga, D., Piro, B., Pham, M.C., Crispin, X., Berggren, M., Horowitz, 
G., 2010. A water-gate organic field-effect transistor. Advanced Materials 22, 2565–2569. 
Kergoat, Loïg, Piro, B., Berggren, M., Horowitz, G., Pham, M.C., 2012. Advances in organic 
transistor-based biosensors: From organic electrochemical transistors to electrolyte-gated 
organic field-effect transistors. Analytical and Bioanalytical Chemistry 402, 1813–1826. 
Kergoat, Loig, Piro, B., Berggren, M., Pham, M.C., Yassar, A., Horowitz, G., 2012. DNA 
detection with a water-gated organic field-effect transistor. Organic Electronics 13, 1–6. 
Kumar, S.T., Jagannath, S., Francois, C., Vanderstichele, H., Stoops, E., Lashuel, H.A., 2020. 
Characterization and validation of 15 α-synuclein conformation-specific antibodies using 
well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct 
structures and morphology: How specific are the conformation-specific α-syniclein 
32 
 
antibodies. bioRxiv 1–54. DOI: 10.1101/2020.06.15.151514 
Lee, B.Y., Sung, M.G., Lee, J., Baik, K.Y., Kwon, Y.K., Lee, M.S., Hong, S., 2011. Universal 
parameters for carbon nanotube network-based sensors: Can nanotube sensors be 
reproducible? ACS Nano 5, 4373–4379. 
Lee, P.H., Lee, G., Park, H.J., Bang, O.Y., Joo, I.S., Huh, K., 2006. The plasma alpha-synuclein 
levels in patients with Parkinson’s disease and multiple system atrophy. Journal of Neural 
Transmission 113, 1435–1439. 
Leonardi, F., Casalini, S., Zhang, Q., Galindo, S., Gutiérrez, D., Mas-Torrent, M., 2016. 
Electrolyte-Gated Organic Field-Effect Transistor Based on a Solution Sheared Organic 
Semiconductor Blend. Advanced Materials 28, 10311–10316. 
Leonardi, F., Tamayo, A., Casalini, S., Mas-Torrent, M., 2018. Modification of the gate electrode 
by self-assembled monolayers in flexible electrolyte-gated organic field effect transistors: 
Work function: Vs. capacitance effects. RSC Advances 8, 27509–27515. 
Macchia, E., Manoli, K., Holzer, B., Di Franco, C., Ghittorelli, M., Torricelli, F., Alberga, D., 
Mangiatordi, G.F., Palazzo, G., Scamarcio, G., Torsi, L., 2018. Single-molecule detection 
with a millimetre-sized transistor. Nature Communications 9. 
Magliulo, M., De Tullio, D., Vikholm-Lundin, I., Albers, W.M., Munter, T., Manoli, K., Palazzo, 
G., Torsi, L., 2016. Label-free C-reactive protein electronic detection with an electrolyte-
gated organic field-effect transistor-based immunosensor. Analytical and Bioanalytical 
Chemistry 408, 3943–3952. 
Magliulo, M., Mallardi, A., Mulla, M.Y., Cotrone, S., Pistillo, B.R., Favia, P., Vikholm-Lundin, 
33 
 
I., Palazzo, G., Torsi, L., 2013. Electrolyte-gated organic field-effect transistor sensors based 
on supported biotinylated phospholipid bilayer. Advanced Materials 25, 2090–2094. 
Parkula, V., Berto, M., Diacci, C., Patrahau, B., Di Lauro, M., Kovtun, A., Liscio, A., Sensi, M., 
Samorì, P., Greco, P., Bortolotti, C.A., Biscarini, F., 2020. Harnessing Selectivity and 
Sensitivity in Electronic Biosensing: A Novel Lab-on-Chip Multigate Organic Transistor. 
Analytical Chemistry. 
Paterson, A.F., Treat, N.D., Zhang, W., Fei, Z., Wyatt-Moon, G., Faber, H., Vourlias, G., Patsalas, 
P.A., Solomeshch, O., Tessler, N., Heeney, M., Anthopoulos, T.D., 2016. Small 
Molecule/Polymer Blend Organic Transistors with Hole Mobility Exceeding 13 cm2V−1s−1. 
Advanced Materials 28, 7791–7798. 
Pérez-Rodríguez, A., Temiño, I., Ocal, C., Mas-Torrent, M., Barrena, E., 2018. Decoding the 
vertical phase separation and its impact on C8-BTBT/PS Transistors properties. ACS Applied 
Materials & Interfaces 10, 7296–7303. 
Rivnay, J., Inal, S., Salleo, A., Owens, R.M., Berggren, M., Malliaras, G.G., 2018. Organic 
electrochemical transistors. Nature Reviews Materials 3, 17086. 
Roberts, M.E., Mannsfeld, S.C.B., Queralto, N., Reese, C., Locklin, J., Knoll, W., Bao, Z., 2008. 
Water-stable organic transistors and their application in chemical and biological sensors. 
Proceedings of the National Academy of Sciences 105, 12134–12139. 
Shi, M., Zabetian, C.P., Hancock, A.M., Ginghina, C., Hong, Z., Yearout, D., Chung, K.A., Quinn, 
J.F., Peskind, E.R., Galasko, D., Jankovic, J., Leverenz, J.B., Zhang, J., 2010. Significance 
and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson’s disease. Neuroscience 
34 
 
Letters 480, 78–82. 
Song, H.Y., Zhou, X., Hobley, J., Su, X., 2012. Comparative study of random and oriented 
antibody immobilization as measured by dual polarization interferometry and surface 
plasmon resonance spectroscopy. Langmuir 28, 997–1004. 
Spillantini, M.G., Goedert, M., 2000. The Alpha-Synucleinopathies : Parkinson’s Disease, 
Dementia with Lewy Bodies, and Multiple. Annals New York Academy of Sciences 920, 16–
27. 
Temiño, I., Del Pozo, F.G., Ajayakumar, M.R., Galindo, S., Puigdollers, J., Mas-Torrent, M., 
2016. A Rapid, Low-Cost, and Scalable Technique for Printing State-of-the-Art Organic 
Field-Effect Transistors. Advanced Materials Technologies 1, 1–7. 
Torsi, L., Farinola, G.M., Marinelli, F., Tanese, M.C., Omar, O.H., Valli, L., Babudri, F., 
Palmisano, F., Zambonin, P.G., Naso, F., 2008. A sensitivity-enhanced field-effect 
chiralsensor. Nature Materials 7, 412–417. 
Torsi, L., Magliulo, M., Manoli, K., Palazzo, G., 2013. Organic field-effect transistor sensors: A 
tutorial review. Chemical Society Reviews 42, 8612–8628. 
Twohig, D., Nielsen, H.M., 2019. α -synuclein in the pathophysiology of Alzheimer ’ s disease. 
Molecular Neurodegeneration 14, 1–19. 
Van De Burgt, Y., Lubberman, E., Fuller, E.J., Keene, S.T., Faria, G.C., Agarwal, S., Marinella, 
M.J., Alec Talin, A., Salleo, A., 2017. A non-volatile organic electrochemical device as a 
low-voltage artificial synapse for neuromorphic computing. Nature Materials 16, 414–418. 
35 
 
Walt, D.R., Agayn, V.I., 1994. The chemistry of enzyme and protein immobilization with 
glutaraldehyde. TrAC - Trends in Analytical Chemistry 13, 425–430. 
Wang, N., Yang, A., Fu, Y., Li, Y., Yan, F., 2019. Functionalized Organic Thin Film Transistors 
for Biosensing. Accounts of Chemical Research 52, 277–287. 
Wennström, M., Surova, Y., Hall, S., Nilsson, C., Minthon, L., Boström, F., Hansson, O., Nielsen, 
H.M., 2013. Low CSF Levels of Both α-Synuclein and the α-Synuclein Cleaving Enzyme 
Neurosin in Patients with Synucleinopathy. PLoS ONE 8. 
Xu, D., Huang, X., Guo, J., Ma, X., 2018. Biosensors and Bioelectronics Automatic smartphone-
based micro fl uidic biosensor system at the point of care. Biosensors and Bioelectronic 110, 
78–88. 
Xu, K., Zhou, R., Takei, K., Hong, M., 2019. Toward Flexible Surface-Enhanced Raman 
Scattering (SERS) Sensors for Point-of-Care Diagnostics. Advanced Science 6, 1900925. 
Yang, Z., Zhao, Y.P., 2007. Adsorption of His-tagged peptide to Ni, Cu and Au (1 0 0) surfaces: 
Molecular dynamics simulation. Engineering Analysis with Boundary Elements 31, 402–409. 
Young, M.B., Oh, B.K., Lee, W., Won, H.L., Choi, J.W., 2005. Study on orientation of 
immunoglobulin G on protein G layer. Biosensors and Bioelectronics 21, 103–110. 
Zeng, F., Duan, W., Zhu, B., Mu, T., Zhu, L., Guo, J., 2019. Paper-Based Versatile Surface-
Enhanced Raman Spectroscopy Chip with Smartphone-Based Raman Analyzer for Point-of-
Care Application. Analytical Chemistry 91, 1064–1070. 
Zhang, Q., Leonardi, F., Casalini, S., Temiño, I., Mas-Torrent, M., 2016. High performing 
36 
 
solution-coated electrolyte-gated organic field-effect transistors for aqueous media operation. 
Scientific Reports 6, 1–10. 
Zhao, K., Wodo, O., Ren, D., Khan, H.U., Niazi, M.R., Hu, H., Abdelsamie, M., Li, R., Li, E.Q., 
Yu, L., Yan, B., Payne, M.M., Smith, J., Anthony, J.E., Anthopoulos, T.D., Thoroddsen, S.T., 
Ganapathysubramanian, B., Amassian, A., 2016. Vertical Phase Separation in Small 
Molecule:Polymer Blend Organic Thin Film Transistors Can Be Dynamically Controlled. 
Advanced Functional Materials 26, 1737–1746. 
 
